en
Scientific article
English

Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rgnull RIP-DTR mice engrafted with human islets

Published inDiabetes, metabolic syndrome and obesity, vol. 8, p. 387-398
Publication date2015
Citation (ISO format)
BORTELL, Rita et al. Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rgnull RIP-DTR mice engrafted with human islets. In: Diabetes, metabolic syndrome and obesity, 2015, vol. 8, p. 387–398. doi: 10.2147/DMSO.S87253
Main files (1)
Article (Submitted version)
accessLevelPublic
Identifiers
ISSN of the journal1178-7007
588views
517downloads

Technical informations

Creation12/01/2015 4:00:00 PM
First validation12/01/2015 4:00:00 PM
Update time03/15/2023 12:09:03 AM
Status update03/15/2023 12:09:02 AM
Last indexation01/16/2024 8:15:59 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack